Leah Neufeld
Personalreferent bei IMMUNEERING CORPORATION
Vermögen: 13 940 $ am 31.05.2024
Aktive Positionen von Leah Neufeld
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IMMUNEERING CORPORATION | Personalreferent | 20.10.2022 | - |
Karriereverlauf von Leah Neufeld
Ehemalige bekannte Positionen von Leah Neufeld
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PREVAIL THERAPEUTICS INC. | Personalreferent | 01.01.2019 | 01.01.2021 |
INTERCEPT PHARMACEUTICALS, INC. | Personalreferent | 01.01.2015 | 01.01.2019 |
NPS PHARMACEUTICALS, INC. | Personalreferent | 01.01.2014 | 01.01.2015 |
Daiichi Sankyo Pharma, Inc.
Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Daiichi Sankyo Pharma, Inc. is a company that manufactures and sells pharmaceutical products. The company is based in Parsippany, NJ. | Personalreferent | 01.01.2009 | 01.01.2014 |
JOHNSON & JOHNSON | Personalreferent | 01.01.2002 | 01.01.2009 |
Ausbildung von Leah Neufeld
American University | Undergraduate Degree |
The Johns Hopkins University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Human Resources Officer | 6 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
IMMUNEERING CORPORATION | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Private Unternehmen | 3 |
---|---|
Prevail Therapeutics, Inc.
Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Daiichi Sankyo Pharma, Inc.
Daiichi Sankyo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Daiichi Sankyo Pharma, Inc. is a company that manufactures and sells pharmaceutical products. The company is based in Parsippany, NJ. | Health Technology |
- Börse
- Insiders
- Leah Neufeld
- Erfahrung